FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling RFK Jr. & claimed regenerative peptides like BPC 157 The Niche FDA to weigh easing limits on unproven peptides promoted by RFK Jr. In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Examples of successful administration mechanisms for the delivery of Download Scientific Diagram